Recombinant Lactobacillus plantarum tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG (mnmG), partial

Shipped with Ice Packs
In Stock

Description

Overview of Recombinant Lactobacillus plantarum tRNA Uridine 5-Carboxymethylaminomethyl Modification Enzyme MnmG (mnmG), Partial

Recombinant Lactobacillus plantarum tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG (mnmG), partial, refers to a genetically engineered form of the MnmG enzyme derived from the bacterium Lactobacillus plantarum. MnmG is involved in the modification of transfer RNA (tRNA), specifically catalyzing the addition of a carboxymethylaminomethyl group to uridine at the 5th position of the tRNA molecule. This modification is crucial for maintaining the fidelity and efficiency of translation during protein synthesis . The term "partial" indicates that the recombinant form may not represent the entire, full-length enzyme but rather a fragment or variant that retains some level of enzymatic activity or function.

Role and Function of MnmG Enzyme

MnmG enzymes are essential for modifying tRNAs, which are central to the translation of genetic code into proteins. The specific modification catalyzed by MnmG, the addition of a carboxymethylaminomethyl group to uridine, affects codon reading and translational accuracy . Modified nucleosides in tRNA enhance the stability and structural integrity of tRNA molecules, ensuring proper interaction with mRNA and ribosomes.

Lactobacillus plantarum as a Model Organism

Lactobacillus plantarum is a Gram-positive bacterium commonly found in fermented foods and the gastrointestinal tract of humans . It has a high survival capacity in the human gut and is considered to have beneficial effects on human health, making it a widely used probiotic . L. plantarum's large genome enables it to inhabit diverse environments by utilizing a broad range of carbohydrates . Its safety and ease of genetic manipulation make it a suitable host for recombinant protein production .

Recombinant Production and Applications

Lactiplantibacillus plantarum is a potential microorganism for recombinant protein production and secretion . Genetic engineering techniques allow scientists to modify L. plantarum to produce specific proteins or enzymes, such as the MnmG enzyme . Recombinant production involves introducing a gene encoding the target protein into L. plantarum, which then expresses the gene and produces the protein. This approach is useful for producing large quantities of enzymes for various applications, including industrial processes, research, and therapeutic purposes.

Research Findings and Data

While specific research findings and data tables directly focusing on the "partial" recombinant form of Lactobacillus plantarum tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG (mnmG) are not available in the provided , related research provides valuable context.

  • tRNA Modification and Function: Studies on tRNA modifications in L. plantarum have shown the presence of modified nucleosides, such as lysidine, which are critical for translational accuracy . Mass spectrometry data confirms the presence of these modifications in vivo.

  • Metabolic Pathways and Antimicrobial Activity: Research integrating metabolomics and genomics of L. plantarum strains has identified various metabolites and pathways associated with antimicrobial activity . While not directly related to MnmG, these studies highlight the diverse metabolic capabilities of L. plantarum and its potential for producing bioactive compounds.

  • Recombinant Protein Production: L. plantarum has been explored as a host for recombinant protein production . Signal peptides have been identified to enhance the secretion of heterologous proteins, indicating the potential for optimizing the production of enzymes like MnmG.

Multi-Omics Approaches

Integrating genomics, transcriptomics, and metabolomics provides a holistic understanding of the biosynthetic capabilities of L. plantarum . These approaches enable the identification of key metabolites, pathways, and regulatory mechanisms involved in various biological processes, including tRNA modification and antimicrobial activity. By combining LC-MS analysis with genomic annotations, researchers can validate specific RiPPs and identify novel bioactive compounds .

Tables

Since there is no specific data available regarding "Lactobacillus plantarum tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG (mnmG), partial," the below tables provide generalized information regarding Lactobacillus and its function.

Table 1: Key Metabolites Identified in Lactiplantibacillus plantarum UTNGt2

MetaboliteCategoryPotential Function
4-Hydroxyphenyllactic acidOrganic AcidAntimicrobial Activity
Benzoic AcidOrganic AcidAntimicrobial Activity
Lauric AcidFatty AcidAntimicrobial Activity
Val-Leu-Pro-Val-Pro-GlnOligopeptideAntimicrobial & Probiotic Enhancement

Table 2: Recombinant Protein Production in Lactobacillus plantarum

FeatureDescription
Host OrganismLactobacillus plantarum
Target ProteinVarious, including α-amylase and surface-displayed proteins
Signal PeptidesLp_3050, Lp_2145, Lp_0373
ApplicationsIndustrial enzyme production, therapeutic applications

Product Specs

Form
Lyophilized powder
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates. Shipping with dry ice is available upon request; please contact us in advance for pricing.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Before opening, briefly centrifuge the vial to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and can serve as a guideline.
Shelf Life
Shelf life depends on storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot to prevent repeated freeze-thaw cycles.
Tag Info
The tag type is determined during manufacturing. Specific tag requests should be communicated beforehand to allow for preferential development.
Synonyms
mnmG; gidA; lp_3681; tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG; Glucose-inhibited division protein A
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Lactobacillus plantarum (strain ATCC BAA-793 / NCIMB 8826 / WCFS1)
Target Names
mnmG
Uniprot No.

Target Background

Function
MnmG is a NAD-binding protein that catalyzes the addition of a carboxymethylaminomethyl (cmnm) group to the wobble position (U34) of specific tRNAs, resulting in the formation of tRNA-cmnm5s2U34.
Database Links

KEGG: lpl:lp_3681

STRING: 220668.lp_3681

Protein Families
MnmG family
Subcellular Location
Cytoplasm.

Q&A

What is the MnmE-MnmG complex and what role does it play in tRNA modification?

The MnmE-MnmG complex is a crucial enzymatic system responsible for modifying the wobble uridine (U34) at position 5 in tRNA molecules. This modification involves the addition of a carboxymethylaminomethyl group to uridine, creating the cmnm5U34 modification. The complex functions through a collaborative mechanism where:

  • MnmE binds the one-carbon donor 5,10-CH₂-THF (5,10-methylenetetrahydrofolate)

  • MnmG binds tRNA, FAD, and NADH as cofactors

  • Together, they transfer the methylene group onto the C5 atom of tRNA U34 via an FADH iminium intermediate

This modification is essential for accurate and efficient translation of mRNA codons, particularly those ending in A or G. The process involves significant conformational changes in the complex, which adopts different oligomeric states during its GTPase cycle depending on the bound nucleotide .

Why is Lactobacillus plantarum used as an expression system for recombinant proteins?

Lactobacillus plantarum serves as an excellent expression system for recombinant proteins due to several advantageous properties:

  • It is recognized as a Generally Recognized As Safe (GRAS) organism suitable for biological therapies

  • It can efficiently express and display target proteins on its surface

  • It functions as a probiotic with high adhesion to intestinal cells

  • It possesses strong anti-inflammatory and immunoregulatory functions

  • It can survive harsh gastrointestinal conditions (low pH, high temperature, bile salts)

  • It can be administered orally, making it suitable for mucosal vaccine delivery

These properties make L. plantarum particularly valuable for developing food-grade oral vaccines and therapeutic proteins that require delivery through the gastrointestinal tract while maintaining stability and functionality .

What are the key components of a recombinant L. plantarum expression system?

A functional recombinant L. plantarum expression system typically includes:

  • Vector Selection: Specialized plasmid vectors compatible with L. plantarum transformation

  • Promoter Systems: Inducible promoters like SppIP-controlled systems that allow regulated expression of target proteins

  • Signal Peptides: For surface display or secretion of target proteins

  • Codon Optimization: Adaptation of target gene codons to match L. plantarum codon usage bias, which significantly enhances expression efficiency

  • Selection Markers: Appropriate antibiotic resistance or other markers for selecting transformed bacteria

  • Purification Tags: Addition of tags that facilitate purification of the expressed protein if needed

The expression efficiency is highly dependent on these parameters, particularly codon optimization, which must account for the specific codon usage bias of L. plantarum to achieve maximum protein yield .

How does the mechanism of methylene transfer via FADH₂ occur in the MnmE-MnmG complex?

The MnmE-MnmG complex employs a sophisticated mechanism for transferring the methylene group to tRNA U34:

  • FADH₂ in MnmG acts as the primary electron donor for the reaction

  • The methylene group from 5,10-CH₂-THF is transferred onto the C5 atom of tRNA U34 through the formation of a covalent FADH iminium intermediate

  • This iminium intermediate serves as an activated form that facilitates the nucleophilic addition of the substrate glycine

  • The addition of glycine produces the final cmnm (carboxymethylaminomethyl) modification on the uridine base

This process requires precise spatial coordination of multiple components: tRNA binding to MnmG, 5,10-CH₂-THF binding to MnmE, and the coordination of FAD and NADH cofactors within MnmG . Recent cryo-EM structural studies have revealed large conformational changes in the complex that are essential for bringing these various substrates and cofactors together in a concerted manner during the tRNA modification reaction .

What are the critical parameters for optimizing recombinant protein expression in L. plantarum?

Optimizing recombinant protein expression in L. plantarum requires careful consideration of multiple parameters:

ParameterOptimal ConditionsEffect on Expression
Inducer Concentration50 ng/mL SppIPMaximizes protein yield without toxicity
Temperature37°COptimal for protein folding and cellular metabolism
Induction Time6-10 hoursProvides sufficient time for protein accumulation
Codon OptimizationL. plantarum-specificCan increase expression by 2-15 fold
Growth PhaseMid-logarithmicBalances cell density with metabolic activity
Media CompositionMRS with appropriate supplementsProvides necessary nutrients for growth and expression
pH6.0-6.5Maintains optimal cellular function

Research has shown that the highest protein yield is achieved when cells are induced with 50 ng/mL SppIP (inducer) at 37°C for 6-10 hours . Flow cytometry analysis has demonstrated that under optimized conditions, the positive rate of target protein expression can reach approximately 37.5% in recombinant strains compared to just 2.5% in parental strains .

How do structural changes in the MnmE-MnmG complex relate to its catalytic function?

The MnmE-MnmG complex undergoes significant structural rearrangements that directly influence its catalytic function:

  • Nucleotide-Dependent Conformational Changes: SAXS studies have revealed that the complex adopts different oligomeric states depending on the bound nucleotide (GDP vs. GTP)

  • L-shaped vs. Symmetric Arrangements: In the GDP-bound state, the complex forms an asymmetric L-shaped structure, while different conformations are observed with other nucleotides

  • Domain Movements: Large domain movements occur during the catalytic cycle to properly position substrates and cofactors

  • Active Site Formation: The conformational changes create the appropriate microenvironment for the chemical reactions to occur, bringing distant catalytic residues into proximity

These structural transitions are essential for coordinating the various steps of the reaction, including:

  • Binding of 5,10-CH₂-THF to MnmE

  • Binding of tRNA, FAD, and NADH to MnmG

  • Formation of the FADH iminium intermediate

  • Transfer of the methylene group to the tRNA substrate

Recent cryo-EM studies have provided high-resolution insights into these structural dynamics, offering a deeper understanding of the molecular basis for the enzyme's catalytic mechanism .

What methods are most effective for detecting and quantifying recombinant protein expression in L. plantarum?

Several complementary methods can be employed to effectively detect and quantify recombinant protein expression in L. plantarum:

  • Transmission Electron Microscopy (TEM): Enables direct visualization of proteins on the bacterial surface, allowing assessment of morphological changes and confirmation of surface display

  • Indirect Immunofluorescence Assay (IFA): Provides information about protein localization and reactivity, particularly useful for proteins displayed on the bacterial surface

  • Flow Cytometry: Quantifies the percentage of bacteria expressing the target protein in a population, with studies showing expression rates of approximately 37.5% in optimized recombinant strains

  • Western Blotting: Allows specific detection and semi-quantitative analysis of the target protein

  • ELISA: Enables quantitative measurement of protein expression levels

  • Mass Spectrometry: Provides detailed characterization of the expressed protein, including post-translational modifications

For studying the stability of recombinant proteins, researchers have successfully employed experimental designs that test protein integrity under varying conditions such as temperature (37°C or 50°C for 20 min), pH values (pH 1.5 or 7 for 30 min), and bile salt concentrations (0%, 0.2%, or 0.5% for 2 h) .

How can one design experiments to evaluate the immunogenicity of recombinant L. plantarum expressing target antigens?

Designing robust experiments to evaluate immunogenicity requires a multi-faceted approach:

  • Animal Model Selection:

    • Choose appropriate models (mice, rats, etc.) based on research questions

    • Consider using transgenic models if specific immune pathway investigation is required

  • Administration Protocol:

    • Route: Oral administration is most common for L. plantarum, mimicking natural exposure

    • Dosage: Typically 10⁸-10¹⁰ CFU per dose based on previous studies

    • Schedule: Prime-boost regimens with 2-3 week intervals between doses

  • Immune Response Assessment:

    • Humoral Immunity:

      • Measure serum IgG, IgG1, and other antibody isotypes by ELISA

      • Quantify mucosal sIgA in fecal samples

    • Cell-Mediated Immunity:

      • Flow cytometric analysis of CD4+ T cells in mesenteric lymph nodes

      • Enumeration of IgA+ B cells in Peyer's patches

      • Cytokine profiling (IL-4, IFN-γ, IL-17, etc.)

  • Controls:

    • Non-recombinant L. plantarum strain (empty vector control)

    • PBS control group

    • Positive control group (conventional vaccine if available)

  • Functional Assays:

    • Neutralization assays (for viral antigens)

    • Protection studies against challenge

Research has demonstrated that recombinant L. plantarum can significantly increase levels of IgG and IgG1 in serum and sIgA in feces, while also enriching CD4+ T cells in mesenteric lymph nodes and IgA+ B cells in Peyer's patches, indicating robust activation of both systemic and mucosal immunity .

How should researchers analyze microbiome changes induced by recombinant L. plantarum administration?

Analysis of microbiome alterations requires comprehensive bioinformatic approaches:

  • Alpha Diversity Metrics:

    • Calculate Chao1 index for species richness

    • Determine observed species index

    • Compute Shannon-Wiener index for species diversity

    • Assess Good's coverage to ensure adequate sampling depth

  • Beta Diversity Analysis:

    • Perform principal coordinate analysis (PCoA) to visualize differences in microbial community structure

    • Conduct non-metric multidimensional scaling (NMDS)

    • Use PERMANOVA to test for significant differences between groups

  • Taxonomic Profiling:

    • Analyze OTU (Operational Taxonomic Unit) clustering at 97% identity

    • Annotate species composition for each sample

    • Create Venn diagrams to identify unique and shared OTUs between treatment groups

  • Functional Prediction:

    • Employ PICRUSt or similar tools to predict functional changes in the microbiome

    • Focus on metabolic pathways and immune regulation functions altered by recombinant L. plantarum

  • Statistical Approaches:

    • Apply appropriate statistical tests with correction for multiple comparisons

    • Use linear discriminant analysis (LDA) to identify biomarker taxa

    • Consider longitudinal analysis for time-course experiments

Research has shown that recombinant L. plantarum can significantly increase species diversity (Shannon-Wiener index) and species richness (Chao1 index) in the gut microbiota, with distinct OTU profiles compared to control groups .

What are the most common pitfalls in analyzing tRNA modification enzyme activity and how can they be avoided?

Several challenges arise when analyzing tRNA modification enzyme activity:

  • Substrate Complexity:

    • Pitfall: Using inappropriate tRNA substrates that lack the necessary features for recognition

    • Solution: Employ well-characterized tRNA substrates with known modification status; consider using synthetic tRNAs with site-specific modifications

  • Multi-factor Enzyme Systems:

    • Pitfall: Analyzing MnmG in isolation when it functions in complex with MnmE

    • Solution: Reconstitute the complete MnmE-MnmG complex for accurate activity assessment

  • Cofactor Dependencies:

    • Pitfall: Overlooking the requirement for multiple cofactors (FAD, NADH, GTP)

    • Solution: Ensure all necessary cofactors are present at optimal concentrations; conduct cofactor dependency studies

  • Assay Sensitivity:

    • Pitfall: Using detection methods with insufficient sensitivity to detect modifications

    • Solution: Employ high-sensitivity techniques like mass spectrometry or specific antibodies against modified nucleosides

  • Conformational Dynamics:

    • Pitfall: Failing to account for nucleotide-dependent structural changes in the complex

    • Solution: Include appropriate nucleotides (GDP/GTP) in activity assays; consider time-resolved analyses to capture dynamic states

  • Data Interpretation:

    • Pitfall: Misinterpreting partial modifications or reaction intermediates

    • Solution: Use complementary analytical approaches to validate findings; include appropriate controls for each step of the modification pathway

By addressing these potential pitfalls through careful experimental design and comprehensive controls, researchers can obtain more reliable and interpretable data on tRNA modification enzyme activity.

What are the promising applications of recombinant L. plantarum beyond vaccine development?

Recombinant L. plantarum holds potential for diverse applications beyond vaccine delivery:

  • Therapeutic Protein Delivery:

    • Expression of anti-inflammatory cytokines for inflammatory bowel disease treatment

    • Delivery of enzymes to address metabolic deficiencies

    • Production of antibody fragments for passive immunization

  • Microbiome Modulation:

    • Engineered strains that can selectively enhance beneficial gut bacteria

    • Expression of prebiotics or antimicrobial peptides to shape microbiome composition

    • Development of strains that can detect and respond to dysbiosis

  • Metabolic Engineering:

    • Production of essential nutrients or vitamins in the gut

    • Detoxification of harmful compounds in food or the intestinal environment

    • Synthesis of beneficial metabolites that support gut barrier function

  • Diagnostic Applications:

    • Development of biosensor strains that detect specific pathogens or metabolites

    • Engineered bacteria that change color or produce measurable signals in response to disease markers

  • Delivery of RNA-based Therapeutics:

    • Expression and delivery of therapeutic RNAs (siRNA, miRNA) to target specific disease pathways

    • Protection of RNA molecules from degradation in the gastrointestinal tract

The remarkable stability of recombinant proteins expressed in L. plantarum under adverse conditions (50°C, pH 1.5, bile salts) makes these applications particularly viable for in vivo use .

How might advances in structural biology further elucidate the MnmE-MnmG complex mechanism?

Recent breakthroughs in structural biology techniques offer exciting opportunities to further unravel the MnmE-MnmG complex mechanism:

  • Time-Resolved Cryo-EM:

    • Capturing intermediate states during the catalytic cycle

    • Visualizing conformational changes associated with different nucleotide-bound states

    • Monitoring structural rearrangements during substrate binding and product release

  • Integrative Structural Biology:

    • Combining cryo-EM with molecular dynamics simulations

    • Supplementing structural data with hydrogen-deuterium exchange mass spectrometry

    • Correlating structure with single-molecule FRET measurements of dynamics

  • Structure-Guided Engineering:

    • Designing mutants to test hypotheses about catalytic mechanisms

    • Creating modified enzymes with altered substrate specificity

    • Developing inhibitors based on structural insights

  • In Situ Structural Biology:

    • Studying the complex in a cellular context rather than with purified components

    • Understanding how cellular factors influence complex assembly and function

    • Visualizing interactions with tRNA and other components in the cellular environment

  • Artificial Intelligence Applications:

    • Using machine learning to predict structural changes in response to different conditions

    • Identifying cryptic binding sites or allosteric networks

    • Predicting the impact of mutations on complex stability and function

These approaches could resolve remaining questions about how different substrates and cofactors are coordinated during the tRNA modification reaction, with 5,10-CH₂-THF binding to MnmE, and tRNA, FAD, and NADH binding to MnmG .

What technological advances could enhance the efficiency of recombinant protein expression in L. plantarum?

Several emerging technologies could significantly improve recombinant protein expression in L. plantarum:

  • CRISPR-Cas9 Genome Engineering:

    • Precise modification of host genome to enhance protein production

    • Knockout of proteases that might degrade recombinant proteins

    • Integration of expression cassettes into optimal genomic locations

  • Synthetic Biology Approaches:

    • Design of completely synthetic promoters with enhanced strength and regulability

    • Construction of artificial secretion signals optimized for L. plantarum

    • Development of orthogonal expression systems with minimal cross-talk

  • Computational Design:

    • AI-driven optimization of codon usage beyond current approaches

    • Prediction and elimination of RNA secondary structures that impede translation

    • De novo design of protein variants with enhanced stability in the L. plantarum cell wall

  • High-Throughput Screening:

    • Microfluidic systems for rapid testing of expression variants

    • Fluorescence-activated cell sorting (FACS) for isolating high-expressing clones

    • Automated systems for parallel optimization of multiple expression parameters

  • Novel Induction Systems:

    • Development of inducer-free, auto-induction systems

    • Creation of expression systems responsive to gut environmental cues

    • Light-controlled or temperature-controlled expression systems for precise regulation

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.